首页>
外国专利>
AGONISTS OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR A7 SUBTYPE FOR USE IN THE TREATMENT OF COGNITIVE SYMPTOMS OF SCHIZOPHRENIA
AGONISTS OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR A7 SUBTYPE FOR USE IN THE TREATMENT OF COGNITIVE SYMPTOMS OF SCHIZOPHRENIA
展开▼
机译:神经元烟碱乙酰胆碱受体A7亚型的治疗精神分裂症的症状
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to a pharmaceutical composition for use in the treatment of cognitive symptoms of schizophrenia comprising administering a therapeutically effective amount of a selective agonist of neuronal nicotinic acetylcholine receptor a7 subtype and a pharmaceutically acceptable. The selective agonist of neuronal nicotinic acetylcholine receptor a7 subtype is preferably (4s)-4-(5- 3 7 phenyl-l,3,4-thiadiazol-2-yloxy)-l- azatricyclo[3.3.1.13,7 ]decane, N- [2-(pyridin-3-ylmethyl)-l-azabicyclo[2.2.2]oct-3-yl]-l- benzofuran-2- carboxamide, N-[(3R)-l-azabicyclo[2.2.2]oct-3-yl]-7-chloro-l- benzothiophene-2-carboxamide, (R)-7-chloro-N-(quinuclidin-3-yl) benzo[b]thiophene-2- carboxamide or a salt thereof.
展开▼